Latest News about ESALY
Recent news which mentions ESALY
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
September 28, 2022
From Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
September 28, 2022
From Benzinga
Why Cassava Sciences Shares Are Soaring Higher
September 28, 2022
From Benzinga
Why Biogen Stock Is Up 40% Today
September 28, 2022
From Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
September 28, 2022
From Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
September 28, 2022
From Benzinga
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
September 28, 2022
From MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
From Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
From Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
From Benzinga
Here's What Could Make This Beaten-Down Stock a Buy
August 19, 2022
From Motley Fool
From Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
August 03, 2022
From Benzinga
From Motley Fool
Is This Biotech Stock a Bad News Buy?
July 06, 2022
From Motley Fool
From Benzinga
2 Safe Stocks to Buy in a Bear Market
May 21, 2022
From Motley Fool
From Benzinga
From Benzinga
1 Reason to Buy Biogen Now, and 1 Reason to Wait
May 05, 2022
From Motley Fool
From MarketWatch
Is This Biotech Stock Worth the Trouble?
April 23, 2022
From Motley Fool
What This Regulatory Approval Could Mean for Merck
April 05, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
From Benzinga
From Benzinga
From Benzinga
Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting
February 25, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.